New Inflammatory Bowel Disease Study Findings Recently Were Reported by Researchers at Icahn School of Medicine at Mount Sinai (Second-line Biologic Therapy Following Tumor Necrosis Factor Antagonist Failure: a Real-world Propensity ...)

Media coverage

• Title	New Inflammatory Bowel Disease Study Findings Recently Were Reported by Researchers at Icahn School of Medicine at Mount Sinai (Second-line Biologic Therapy Following Tumor Necrosis Factor Antagonist Failure: a Real-world Propensity ...)
  Media name/outlet	Immunotherapy Daily
  Country/Territory	United States
  Date	26/10/23
  Persons	Ryan Ungaro